Intercept Pharma (ICPT) Misses Q4 EPS Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. PLTR
4. LITE
5. REGN
6. ABBV
7. MRVL
8. CL
9. CHKP
10. MAR

Go back to Intercept Pharma (ICPT) Misses Q4 EPS Views

Intercept Pharmaceuticals Reports 2015 Financial Results and Provides Business Update

February 23, 2016 7:05 AM EST

NEW YORK, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today reported financial results for the fourth quarter and full year ended December 31, 2015 and provided other general business updates. Intercept will hold a conference call and audio webcast today at 8:00 a.m. Eastern Time to review this information with conference call details provided below.

Summary of Program Progress

Primary Biliary Cirrhosis (recently renamed Primary... More